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ABSTRACT 
The present study deals with the development and evaluation of controlled porosity osmotic pump (CPOP) tablets containing 
inclusion complexes of methanolic extract of Garcinia indica fruit rind. Wet granulation method was used for the development of 
core tablets. Core tablets were incorporated with different concentrations of sodium chloride as osmogen and additives. The CPOP 
tablets were coated with cellulose acetate as a wall forming material and HPMC acts as pore forming material in SPM. The 
formulated tablets were evaluated for FTIR, DSC, pre-compression parameters, post compression parameters, in vitro drug release 
study and scanning electron microscopy study. The optimized formulation had no significant effect on the pH and agitation intensity. 
SEM images revealed that no pores were found before dissolution and after dissolution had shown the porous nature of the 
membrane. It was found that the optimized formulation (P4) delivers a drug at a zero-order rate for 12 hours. Short term stability 
study at 40±2ºC /75±5% RH for the months on the optimized formulation indicated that there was no significant change in weight 
variation, % friability, drug content and in vitro drug release. 
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INTRODUCTION 
In recent years, considerable attention has been focused 
on the development of novel drug delivery systems 
(NDDS). Once-daily controlled release preparation is 
often desirable. However, drug release from oral 
controlled release dosage forms may be affected by pH, 
gastric motility, and presence of food 
1,2
. Osmotic 
devices are most promising strategy based system for 
controlled drug delivery as they provides greater 
effectiveness in the treatment of chronic conditions by 
providing zero order drug release and which may reduce 
side effects and also better patient compliance.  
The present study is to develop controlled porosity 
osmotic pump tablets. CPOP tablets were developed 
where the delivery orifices were formed by the 
incorporation of a leachable component in Semi 
permeable membrane (SPM) 3. The core is coated with 
cellulose acetate containing in situ micro pore former 
HPMC. Once CPOP tablets come in contact with the 
aqueous environment of biological system the water 
soluble component dissolves and an osmotic pumping 
system is created in the core. Hence water diffuses into 
the core though the micro porous membrane setting up 
an osmotic gradient and thereby controlling the release 
of drug
4, 5, 6
. 
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Garcinia indica (dried rind known as ‘kokum’), family 
Clusiaceae, a tropical fruit, can be viewed as a wonder 
berry that has a myriad of health benefits and also 
pharmacologically studied for its antioxidative, 
chelating, free radical scavenging, anticancer, anti-
inflammatory, and antiulcer activities
7
.  The methanolic 
extract of Garcinia indica fruit rinds was prepared using 
soxhlet apparatus. It has significant antioxidant and 
cytotoxic activity 
8
.  Therefore the extract was used for 
further formulation development studies. 
MATERIALS AND METHODS 
Fresh kokum fruits were collected and authenticated by 
Botanical Survey of India, Pune, Maharashtra, India. 
Cellulose Acetate was procured from Signet Chemicals 
Corporation Pvt. Ltd., Mumbai, NaCl, HPMC, 
hydroxypropyl-beta-cyclodextrin (HP-ß-CD) was 
procured from Loba chem. Pvt. Ltd., Mumbai. Rest of 
the chemicals and reagents were of Analytical grade. 
Methods: 
Phase Solubility Analysis for Garcinia indica extract 
Phase solubility studies of Garcinia indica extract with 
different concentrations of hydroxypropyl-beta-
cyclodextrin (HP-ß-CD) were performed according to 
the method described by Higuchi and Connors to 
determine stoichiometric proportions of extract with HP-
ß-CD
9-10
. The data were used to determine stability 
constant of the complexes. For this, the stock solution of 
10 mM HP-ß-CD were prepared using distilled water. 
The stock solution was diluted with distilled water to 
give millimole solutions in the range of 02 to 10 mM 
HPß-CD solutions. 20 ml of each solution was filled in 
screw capped vials and the excess quantity of the drug 
was added to each vial separately. The vials were kept 
for shaking at ambient temperature for 48 hrs using a lab 
shaker (Remi). After 48 hrs of shaking to achieve 
equilibrium, 2 ml aliquots are withdrawn at 1 hr interval 
and filtered through Whatman no.1 filter paper. The 
filtered samples are diluted suitably and assayed for drug 
content by specific UV method against a blank. 
Preparation of inclusion complexes  
Preparation of solid complexes of Garcinia indica 
extract with HP-ß-CD was performed by the solvent 
evaporation method
11-13
. Extract with HP-ß-CD in 
different molar ratios (1:1 and 1:2) were taken. First 
cyclodextrin placed in methanol–water system (9:1) with 
continuous stirring on linear motion shaker (Spectra lab 
Whirlmatic, Mumbai; Model No.TH100) for about 24 h. 
The inclusion complex was obtained as dry powder by 
evaporating the solvent at a temperature above 70°C or 
sufficient to evaporate water using rotary evaporator and 
the complexes were collected, weighed, stored in glass 
vial and dried at room temperature. The same procedure 
was adopted to prepare HP-β-CD complexes. 
Compatibility studies of inclusion complexes: 
Fourier Transform Infrared Spectroscopy (FTIR) 
In this method inclusion complexes of extract as well as 
the excipients were mixed thoroughly with potassium 
bromide (1:100) for 3-5 minutes in a mortar and 
compressed into disc using hydraulic press
14
. The pellet 
was kept in the sample holder and scanned from 4000 to 
400 cm-1 in FTIR spectrophotometer (Jasco, Japan). 
Differential Scanning Calorimetry (DSC)  
Physical mixtures of drug and individual excipients in 
the ratio of 1:1 were taken and examined in DSC. 
Individual samples as well as physical mixture of drug 
and excipients were weighed to about 5mg in DSC pan. 
The sample pan was crimped for effective heat 
conduction and scanned in the temperature range of 50-
300ºC. Heating rate of 20ºC min
-1
was used and the 
thermogram obtained was reviewed for evidence of any 
interactions. 
Methods  
Preparation of CPOP tablets  
The core tablets of Garcinia indica inclusion complexes 
were prepared by wet granulation technique with 
varying ratios of the osmogen. Drug and all the 
ingredients except lubricants were weighed and passed 
through 30 mesh screen. The ingredients were manually 
blended homogenously in a mortar by way of geometric 
dilution. The mixture was moistened with non aqueous 
solution and granulated through sieve No.30 and dried in 
a hot air oven at 60ºC for sufficient time (3-4 hrs). The 
dried granules were passed though sieve No.30 and 
blended with magnesium stearate. The homogenous 
blend was then compressed into tablets with standard 
concave punches using 10 station rotary compression 
machines (Mini press, Karnavati, India). 
 
Table 1: Composition of controlled porosity osmotic pump tablets of Garcinia indica 
Ingredients P1 (50%) P2 (60%) P3 (70%) P4 (80%) P5 (90%) P6 (0%) 
GI+ HPβCD 300 300 300 300 300 300 
NaCl 75 90 105 120 135 -- 
Sodium Stach glcollate 4 4 4 4 4 4 
Di calcium Phosphate 69 54 39 24 09 144 
Talc 1 1 1 1 1 1 
Mg stearate 1 1 1 1 1 1 
Total wt 450 mg 
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Coating of core tablets 
15
:  
The coating solution was prepared taking required 
ingredients from table 2 and acetone was added 
quantity sufficient maintaining proper viscosity of 
solution. The coatings of tablets were performed by 
using R & D coater. Hot air is supplied to tablet bed by 
rotating lower speed 10-15 rpm initially. The coating of 
tablets was carried out with the rotation speed of 15-30 
rpm. The spray rate and atomizing air pressure were 1-
2 ml/min and 1-2 kg/cm2 respectively. Inlet and outlet 
air temperature were 35ºC and 55ºC respectively. 
Coated tablets were dried at 50ºC for 12 hrs. The 
process was continued until 10 % weight gain of the 
tablets. The coated tablets were rotated for a further 15 
min under blower. 
Table 2: Coating composition for controlled 
porosity osmotic pump tablets 
Ingredients Quantity 
Cellulose Acetate 398-10  3 grams 
HPMC  4 grams 
Castor oil 2.5 ml 
Acetone 100ml 
 
Precompression parameters 
16 
Evaluation of Granules: 
The prepared granules were evaluated for pre 
compression parameters such as angle of repose, bulk 
density, tapped density and compressibility index 
(Carr’s index). Fixed funnel method was used to 
determine angle of repose.  
Post compression parameters
17-18
 
Thickness  
The uniformity of thickness was measured using digital 
vernier caliper. The average thickness of the tablet was 
calculated. The limit of the thickness deviation of each 
tablet is 5%. 
Measurement of coat thickness  
Film was isolated from the tablets after 18hrs of 
dissolution and dried at 40°C for 1hr. Thickness was 
measured by using electronic digital calipers (Absolute 
digimatic, Mitutoyo Corp. Japan) 
Hardness  
The hardness of tablets can be determined by using 
Monsanto hardness tester.  
Friability test  
Friability test of tablets was performed in a Roche 
friabilator. Twenty tablets of known weight (W1) were 
de-dusted in plastic chamber of friabilator for a fixed 
time of 25 rpm for 4 minutes and weighed gain of 
weight (W2).The percentage of friability was calculated 
using the following equation.  
%Friability= F= ( 1- W2 / W1) 
Where, W1 and W2 are the weight of the tablets before 
and after the test respectively.  
Weight variation test  
The weight variation test is performed by weighing 20 
tablets individually calculating the average weight and 
comparing the individual tablet weights to the average. 
The percentage weight deviation was calculated and 
then compared with USP specifications. 
Uniformity of drug content test  
Powder is made after triturating 10 CPOP tablets from 
each batch with mortar and pestle. The powder weight 
equivalent to one tablet was dissolved in a 100ml 
volumetric flask filled with pH 6.8 phosphate buffer 
and kept on rotary shaker for 24 hrs. in order to 
completely extract the drug. The mixture was filtered, 
and the drug was assayed spectrophotometrically at 253 
nm. 
 In –vitro Release Studies19: 
In vitro drug release for preliminary and factorial 
batches was carried out using USP – type II dissolution 
apparatus (paddle type). The dissolution medium, 900 
ml of 0.1 N HCl at 37 ± 0.5 º C, and 100 rpm  for first 2 
hrs then replaced with 6.8 phosphate buffer and 
continued for 24 hrs. Aliquot volume of 5 ml was 
withdrawn after every 1, 2, 4, 6, 8, 10, 12 and 24 hours 
and replaced with fresh 6.8 phosphate buffer. Collected 
samples were suitably diluted with phosphate buffer 
(pH 6.8) and analyzed at 253 nm using phosphate 
buffer (pH 6.8) as blank. 
Kinetics of Drug Release
20
 
In order to investigate the mode of release from tablets, 
the release data of formulation was analyzed zero order 
kinetics, first order kinetics, Higuchi model and 
Korsmeyer-Peppas and Hixson-Crowell equations to 
ascertain the kinetic modeling of drug release by using 
a PCP Disso Version 2.08 software, and the model with 
the higher correlation coefficient was considered to be 
the best model. 
Effect of Formulation variables
21
 
In order to optimize the formulation to release the drug 
at a constant zero-order release rate, level of pore 
former, effect of weight gain during coating, pH and 
agitation intensity were used as formulation variables.  
Effect of osmogen concentration  
Keeping all the parameters for tablet constant different 
osmogen concentrations were used to prepare tablets. 
The drug release was compared with the different 
osmogen concentration of formulated batches by using 
USP-II dissolution apparatus. 
Effect of pore former concentration 
To study the effect of different amount of pore forming 
agent on drug release, the varying concentration of pore 
former i.e. 2.5 gm, 5 gm, 7.5gm HPMC was used in 
coating. 
Effect of weight gain:  
To study the effect of weight gain of the coating on 
drug release, the core tablets of Garcinia indica 
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inclusion complexes  were coated with coating solution  
in order to achieve a weight gain of 8,10, 12% w/w.  
Effect of pH:  
In-vitro dissolution studies were performed using USP 
dissolution apparatus type II in different release media 
(0.1N HCl phosphate buffer pH 6.8, and 7.4) 
maintained at 37°C ±0.5°C and 100 rpm. The 
optimized formulation (F6) was selected for the study 
of effect of pH. 
Effect of agitation intensity: It is necessary to check 
that the effect of agitation intensity on the drug release. 
In-vitro dissolution studies was performed using USP 
dissolution apparatus type II in 6.8 Phosphate buffer 
maintained at 37°C ±0.5°C. The optimized formulation 
(F6) was subjected to different Agitation intensities 50, 
75 and 100 rpm. The responses were noted.  
Scanning Electron Microscopy
22
:  
Coating membranes of formulation obtained before and 
after complete dissolution of core contents were 
examined for their porous morphology by scanning 
electron microscope. 
Stability study
23
: 
The optimized formulation  (P4) was packed in the 
strips of thick Aluminum foil laminated with PVC and 
stored in ICH certified stability chambers (Thermo lab, 
Stability chamber, Scientific Equipment’s, Pvt. Ltd.) 
maintained at 40ºC and 75% RH for 6 months. The 
tablets were drawn periodically and evaluated for the 
appearance, drug content and dissolution profile. 
RESULT AND DISCUSSION  
Phase solubility analysis of Garcinia indica extract 
On the complexation of the drug with HPß-CD, the 
effect of HPß-CD on the solubility, and the stability 
constant of HPß-CD complex formed were investigated 
by phase solubility studies. The phase solubility curve 
of Garcinia indica extract in the presence of HPβ-CD 
is shown in Figure 1. From this curve, it can be seen 
that the solubility of the extract increases due to the 
formation of an inclusion complex between extract 
and HPβ-CD. A linear increase in solubility of extract 
was observed with an increase in concentration of HPβ-
CD in water. The phase solubility plot showed an 
AL type solubility curve, which indicates that only 1:1 
drug-HPβ-CD inclusion complex was formed in 
solution. The apparent stability constant (K1:1) for the 
Garcinia indica extract: HPβ-CD complex was 
calculated from the solubility data and found to be 
126.81 M
-1
. 
 
 
Figure 1: Solubility study of Garcinia indica and HP β cyclodextrin complexes 
 
Compatibility studies: 
a) FTIR study: Drug polymer interactions were 
studied by FTIR. From the spectra it was observed 
that there was no interaction between the drug and 
excipients (Figure 2) as the characteristic peaks 
remained as such. 
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Figure 2: FTIR Analysis of a) Garcini indica Extract (b) Garcinia indica inclusion complex (c) Beta Cyclodextrin 
(d) NaCl  (e) HPMC (f) Formulation 
b) DSC study:  
DSC thermogram is depicted in Figure 3  indicates that 
the endothermic peak of Garcinia indica extract  at 
93.5ºC and  the endothermic peak of formulation  is 
showing at 102.2º C. There were no significant changes 
in the endotherm peak between drug and formulation.
 
 
Figure 3: DSC Study of Garcinia indica extract and its formulation 
Precompression parameters 
The angle of repose of all formulations was within the 
range of 23.76º-29.45º indicative of excellent and good 
flow ability. The bulk density of powder was found to 
be between 0.72-0.77gm/cm3. The tapped density of the 
granules of batches was found in the range of 0.78 – 
0.85 gm/cm
3
. The bulk density and tapped density was 
used to calculate the percent compressibility of the 
powder. The compressibility index of the powder was 
observed in range of 6.32%-13.25%. The Hausner’s 
ratio was found to be the range of 1.06-1.15 indicating 
good and fair flow ability. 
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Table 3: Evaluation of granules 
Formulation Bulk Density 
(gm/cc) 
Tapped 
Density 
(gm/cc) 
Carr’s Index 
(%) 
Angle of 
Repose(
0
) 
Hausner’s 
Ratio 
Flow 
pattern 
P1 0.73±0.04 0.78±0.04 6.41±0.73 26.93±0.85 1.06±0.02 Good 
P2 0.72±0.09 0.83±0.53 13.25±1.11 29.45±0.98 1.15±0.05 Good 
P3 0.77±0.04 0.85±0.05 9.41±1.43 24.82±1.11 1.10±0.02 Excellent 
P4 0.74±0.07 0.79±0.17 6.32±0.86 26.61±0.65 1.06±0.03 Good 
P5 0.73±0.03 0.80±0.06 8.75±0.48 23.76±0.73 1.09±0.00 Excellent 
P6 0.76±0.05 0.84±0.23 9.52±0.93 25.34±0.43 1.10±0.07 Excellent 
 
Post Compression parameters 
All formulated tablet batches were evaluated for 
thickness, Hardness, weight variation, % friability and 
drug content. All evaluated values were in acceptable 
limits. It is mentioned in table 4.
 
Table 4:  Evaluation of preliminary batches 
         
In vitro dissolution study 
In vitro drug release for preliminary and factorial 
batches was carried out using USP – type II dissolution 
apparatus (paddle type). The percentage drug release 
from formulation P1 to P6 were denoted in figure 4 at 
the end of 12 hrs. Optimized Formulation P4 showed 
69.48 % drug release for 12 hr. 
 
 
Figure 4: In vitro percentage drug release of preliminary batches. 
 
Kinetics of Drug Release 
In present study the dissolution were analyzed by PCP 
Disso Version 2.08 software to study the kinetics of drug 
release mechanism. The result supports Zero order 
release and Hixon crowell dissolution model. The R
2 
value of all dissolution models has been shown in Table 
5.
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Formula 
code 
Thickness* (mm) 
N=3 
Hardness* 
(Kg/cm2) 
Average* Weight 
(gm) 
% 
Friability 
Drug 
content* 
(%) 
 
Before 
coating 
After 
coating 
Before 
coating 
After 
coating 
Before 
coating 
After 
coating 
P1 4.19±0.077 4.69±0.04 6.064±0.20 7.73±0.21 0.452±0.85 0.477±0.46 0.55 98.45±0.58 
P2 4.22±0.058 4.72±0.05 5.975±0.26 7.05±0.17 0.451±0.84 0.476±0.49 0.58 97.34±0.33 
P3 4.23±0.091 4.73±0.05 6.025±0.29 7.56±0.09 0.450±0.37 0.475±0.43 0.64 97.64±0.32 
P4 4.22±0.054 4.72±0.09 5.995±0.27 7.75±0.07 0.452±0.46 0.477±0.45 0.80 96.05±0.19 
P5 4.21±0.062 4.71±0.07 5.99±0.27 7.30±0.22 0.453±0.75 0.478±0.44 0.23 99.89±0.42 
P6 4.20±0.091 4.70±0.08 5.975±0. 7.21±0.34 0.453±0.85 0.479±0.43 0.30 97.53±0.18 
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Table 5:   Kinetics of drug release 
Formulation 
Code 
Zero order First order Matrix Peppas Hixson crowell Best 
Fitting 
Model 
 R K R K R K R K R K  
F1 0.9899 6.8469 0.9981 0.0896 0.9542 16.1448 0.9884 6.7655 0.9972 -0.0272 First 
Order 
F2 0.9979 5.3731 0.9973 -0.0658 0.9439 12.5951 0.9974 5.3697 0.9987 -0.0205 Hix-
Crowell 
F3 0.9961 5.7525 0.9963 -0.0717 0.947 13.5111 0.9887 5.8219 0.9977 -0.0222 Hix-
Crowell 
F4 0.9968 6.1271 0.9918 -0.078 0.942 14.3649 0.9922 6.2647 0.9955 -0.0239 Zero 
order 
F5 0.998 7.2416 0.9796 -0.0987 0.9281 16.873 0.9955 6.6871 0.9889 -0.0295 Zero 
order 
F6 0.989 4.3051 0.9889 -0.0504 0.9172 10.0236 0.9856 3.1693 0.9893 -0.0159 Hix-
crowell 
 
Effect of Formulation variables 
Effect of pore forming agent  
The effect of pore forming agent on in vitro drug release 
was studied by coating the optimized formulation with 
varying concentration of pore former in coating solution 
(3%, 4% and 5% HPMC). It confirms that as the level of 
pore former increases the membrane becomes more 
porous after coming contact with aqueous environment 
resulting in faster drug release.  
 
 
Figure 5: In vitro drug release profile of (P4) at 
different concentration of pore forming agent. 
 
Effect of Weight gain 
To study the effect of weight gain, optimized batch (P4) 
was coated with different weight gain (8, 10 and 12% 
w/w) and was subjected to dissolution in Phosphate 
buffer 6.8. It clearly shows that drug release, decreases 
with an increase in weight gain of membrane. The 
bursting effect of tablet was however absent throughout 
the dissolution study which assures that the formulations 
will remain intact in GIT without any incidence of dose 
dumping. 
 
 
Figure 6: Effect of percent weight gain on drug 
release of optimized formulation 
Effect of pH 
To study the effect of pH on optimized batch (P4) was 
subjected to dissolution studies separately in 0.1 N HCl 
for 2 hrs and phosphate buffer 6.8 up to 12 hrs, 
Phosphate buffer 6.8 and Phosphate buffer 7.4 for 12 
hrs. The system was independent of the pH as there was 
no difference in the drug release. Results demonstrating 
that the developed formulation shows pH independent 
release. 
 
Figure 7: Influence of pH on drug release of 
optimized formualation 
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Effect of pH on drug release 
pH change method 
Phosphate buffer 6.8 
Phosphate buffer 7.4 
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Effect of agitation intensity: 
To study the effect of Agitation intensity, optimized 
batch (P4) was subjected to dissolution in Phosphate 
buffer 6.8 at 50, 75 and 100 rpm. There was no 
significant difference in the release profile of the system 
with change in agitation intensity. 
 
 
Figure 8: Influence of agitation intensity on drug 
release of optimized formulation 
SEM of Coating (before and after dissolution)  
The coating membrane of the osmotic delivery system 
before and after dissolution was examined with the help 
of SEM. Before dissolution (Figure 9a) no pores were 
found in the coating membrane. But after dissolution 
(Figure9 b) comparatively more numbers of pores were 
found in the membrane might be due to leaching or 
removal of entrapped drug from the formulation. The 
porous nature of the membrane was due to the presence 
of pore forming agent HPMC in the formulation. 
 
Figure 9: SEM Micrographs of the coat, a) before 
dissolution b) after dissolution (24 h) after dissolution 
Stability study: 
The optimized formulation was maintained at 40ºC and 
75% RH for 6 months. The tablets were evaluated for 
their appearance, drug content and dissolution profile. 
The results revealed that there was no significant change 
in the parameters. Therefore, the formulation P4 is 
considered to be stable. 
 
Table 6:  Stability study 
 
CONCLUSION  
A porous osmotic pump–based drug delivery system can 
be designed for extended release of Garcinia indica 
extract. It is evident from the results that the rate of drug 
release can be controlled through osmotic pressure of the 
core, level of pore former, and membrane weight with 
release to be fairly independent of pH and hydrodynamic 
conditions of the body. The drug release from the 
developed formulations was inversely proportional to 
the membrane weight gain and directly proportional to 
the concentration of osmogen and the pore forming 
agent. Results of SEM studies confirmed the formation 
of pores in the membrane after coming into contact with 
the aqueous environment. Hence this can be used to 
develop newer formulations to avoid shortcomings of 
conventional dosage forms. 
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Optimized Formulation (P4) 
Initial 1 month 2 months 3 months 6 months 
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